1. Home
  2. RVNC vs TTSH Comparison

RVNC vs TTSH Comparison

Compare RVNC & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • TTSH
  • Stock Information
  • Founded
  • RVNC 1999
  • TTSH 1985
  • Country
  • RVNC United States
  • TTSH United States
  • Employees
  • RVNC N/A
  • TTSH N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • RVNC Health Care
  • TTSH Finance
  • Exchange
  • RVNC Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • RVNC 320.5M
  • TTSH 295.2M
  • IPO Year
  • RVNC 2014
  • TTSH N/A
  • Fundamental
  • Price
  • RVNC $3.67
  • TTSH $7.02
  • Analyst Decision
  • RVNC Hold
  • TTSH
  • Analyst Count
  • RVNC 9
  • TTSH 0
  • Target Price
  • RVNC $7.78
  • TTSH N/A
  • AVG Volume (30 Days)
  • RVNC 2.9M
  • TTSH 119.9K
  • Earning Date
  • RVNC 02-26-2025
  • TTSH 02-27-2025
  • Dividend Yield
  • RVNC N/A
  • TTSH N/A
  • EPS Growth
  • RVNC N/A
  • TTSH N/A
  • EPS
  • RVNC N/A
  • TTSH 0.08
  • Revenue
  • RVNC $256,945,000.00
  • TTSH $352,075,000.00
  • Revenue This Year
  • RVNC $11.28
  • TTSH $8.17
  • Revenue Next Year
  • RVNC $27.21
  • TTSH N/A
  • P/E Ratio
  • RVNC N/A
  • TTSH $87.58
  • Revenue Growth
  • RVNC 25.82
  • TTSH N/A
  • 52 Week Low
  • RVNC $2.30
  • TTSH $5.68
  • 52 Week High
  • RVNC $7.56
  • TTSH $7.50
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 61.28
  • TTSH 58.67
  • Support Level
  • RVNC $3.25
  • TTSH $6.96
  • Resistance Level
  • RVNC $3.70
  • TTSH $7.15
  • Average True Range (ATR)
  • RVNC 0.08
  • TTSH 0.22
  • MACD
  • RVNC 0.09
  • TTSH 0.02
  • Stochastic Oscillator
  • RVNC 95.52
  • TTSH 80.30

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: